Motoharu Shibusawa, Tetsuya Tanimoto. "Quizartinib for Newly Diagnosed
                    <i>FLT3</i>
                    -Internal Tandem Duplication–Negative AML." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco-25-02702